MBCT-vision

  • Research type

    Research Study

  • Full title

    Mindfulness Based Cognitive Therapy for visual symptoms (MBCT-vision): a feasibility study

  • IRAS ID

    266101

  • Contact name

    Sui H. Wong

  • Contact email

    sui.wong@gstt.nhs.uk

  • Sponsor organisation

    Guys & St Thomas' NHSFT

  • Duration of Study in the UK

    1 years, 2 months, 31 days

  • Research summary

    This is a research study on Mindfulness-Based Cognitive Therapy for visual symptoms (MBCT-vision), to treat patients with debilitating symptoms of visual snow (VS), severe light sensitivity (i.e. photophobia) and migrainous visual aura.

    VS is a condition of persistent flickering dots, like that of an out-of-focus analog television screen, affecting the whole visual field. No clinical trials for treatment have been done for VS. Instead, treatment data comes from patient case reports.

    Photophobia describes discomfort or pain to light stimulation. Causes include eye surface issues, migraine, or of an unknown trigger, and can be persistent despite optimum management of underlying causes.

    Patients with migrainous visual aura may have troublesome visual disturbances despite optimum migraine treatment.

    Previous studies have shown that dysfunction in brain pathways contribute to the above conditions.

    Mindfulness-Based Cognitive Therapy is a treatment that combines evidence-based approaches of Mindfulness-Based Stress Reduction and Cognitive Behavioural Therapy (CBT). MBCT is an established 8-week programme designed to develop skills of mindfulness and CBT strategies in individuals, through weekly small-group sessions and structured daily practice between sessions.

    Studies on MBCT and mindfulness-based interventions have shown improvements in psychological resilience; physical health including immune function; and neural changes associated with psychological wellbeing.

    We propose that MBCT, modified to incorporate aspects relevant to persistent and distressing visual symptoms (MBCT-vision), can improve these debilitating symptoms by modifying dysfunctional neural pathways and equip patients with skills that promote psychological resilience and improve coping with residual symptoms.

    For this study, we will assess the use of MBCT-vision in patients with visual snow, migrainous visual aura or photophobia. This will be the first study of a mindfulness-based intervention in this population.

  • REC name

    London - South East Research Ethics Committee

  • REC reference

    19/LO/1615

  • Date of REC Opinion

    19 Nov 2019

  • REC opinion

    Further Information Favourable Opinion